Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Meningeal melanocytosis: a possibly useful treatment for a rare primary brain neoplasm.

Literature DB >> 21249503

Meningeal melanocytosis: a possibly useful treatment for a rare primary brain neoplasm.

Júlia Miró, Roser Velasco, Carles Majós, Miguel Gil, Susana Boluda, Jordi Bruna.

Abstract

Entities: Disease

Mesh：

Year: 2011 PMID： 21249503 DOI： 10.1007/s00415-010-5869-9

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

× No keyword cloud information.

14 in total

1. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.

Authors: M R Middleton; J J Grob; N Aaronson; G Fierlbeck; W Tilgen; S Seiter; M Gore; S Aamdal; J Cebon; A Coates; B Dreno; M Henz; D Schadendorf; A Kapp; J Weiss; U Fraass; P Statkevich; M Muller; N Thatcher
Journal: J Clin Oncol Date: 2000-01 Impact factor: 44.544

2. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases.

Authors: Maja Hofmann; Felix Kiecker; Reinhard Wurm; Lorenz Schlenger; Volker Budach; Wolfram Sterry; Uwe Trefzer
Journal: J Neurooncol Date: 2006-01 Impact factor: 4.130

3. Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.

Authors: Ly Ngo; Maromi Nei; Jon Glass
Journal: Epilepsia Date: 2006-07 Impact factor: 5.864

Review 4. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.

Authors: Marc C Chamberlain; Michael Glantz; Morris D Groves; Wyndham H Wilson
Journal: Semin Oncol Date: 2009-08 Impact factor: 4.929

5. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

Authors: P B Chapman; L H Einhorn; M L Meyers; S Saxman; A N Destro; K S Panageas; C B Begg; S S Agarwala; L M Schuchter; M S Ernstoff; A N Houghton; J M Kirkwood
Journal: J Clin Oncol Date: 1999-09 Impact factor: 44.544

Meningeal melanocytosis: a possibly useful treatment for a rare primary brain neoplasm.

1. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.

2. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases.

3. Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.

Review 4. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.

5. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

6. Primary melanocytic neoplasms of the central nervous systems.

7. Effect of temozolomide on central nervous system relapse in patients with advanced melanoma.

Review 8. Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature.

9. Nevomelanocytic proliferations in the central nervous system of children.

10. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.

1. Two cases of primary leptomeningeal melanomatosis mimicking subacute meningitis.